Notice of first launch, interruption or termination of supply of a human drug
 DateHolder ▼CodeDrugDate fromSubject
 8.3.20213M Deutschland GmbH (MDU)80441Ubistesin forte (sol inj 50x1,7 ml (karpula skl.))12.4.2021R
 8.3.20213M Deutschland GmbH (MDU)80440Ubistesin (sol inj 50x1,7 ml (karpula skl.))7.5.2021R
 8.3.20213M Deutschland GmbH (MDU)76538MEPIVASTESIN (sol inj 50x1,7 ml (karpila))7.5.2021R
 11.1.2022A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)45268Lioton gel 100 000 (gel 1x100 g (tuba Al))11.1.2022O
 17.1.2020A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)84098Spasmomen (tbl flm 30x40 mg (blis.Al/PVC/PVDC))30.4.2020Z
 29.11.2021A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)45268Lioton gel 100 000 (gel 1x100 g (tuba Al))29.11.2021R
 28.9.2022A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)83106Lioton gel 100 000 (gel 1x30 g (tuba Al))28.9.2022O
 16.6.2022A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)83106Lioton gel 100 000 (gel 1x30 g (tuba Al))16.6.2022R
 27.1.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)87018Norvir 100 mg filmom obalené tablety (tbl flm 30x100 mg (fľa.HDPE))1.4.2022Z
 9.6.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)47592LUMIGAN 0,3 mg/ml očná roztoková instilácia (int opo 1x3 ml/0,9 mg (fľ.LDPE))8.6.2022R
 14.6.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)47592LUMIGAN 0,3 mg/ml očná roztoková instilácia (int opo 1x3 ml/0,9 mg (fľ.LDPE))14.6.2022O
 22.3.2023AbbVie Deutschland GmbH & Co. KG (ABV-DE)35456GANFORT 0,3 mg/ml + 5 mg/ml očná roztoková instilácia (int opo 1x3 ml (fľ.LDPE))23.3.2023O
 26.9.2019AbbVie Deutschland GmbH & Co. KG (ABV-DE)40793Humira 40 mg/0,8 ml injekčný roztok (sol inj 2x0,8 ml/40 mg (liek.inj.skl.))1.10.2019Z
 24.2.2023AbbVie Deutschland GmbH & Co. KG (ABV-DE)35456GANFORT 0,3 mg/ml + 5 mg/ml očná roztoková instilácia (int opo 1x3 ml (fľ.LDPE))16.2.2023R
 2.5.2023AbbVie Deutschland GmbH & Co. KG (ABV-DE)2192CVenclyxto 100 mg filmom obalené tablety (tbl flm 7 (7x1)x100 mg (blis.PVC/PE/PCTFE/Al-jednotl.dávka))1.7.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To